The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of immunosuppressed patients with Merkel cell carcinoma treated with immune checkpoint inhibitors.
 
William Mullally
Stock and Other Ownership Interests - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Andrew Brohl
Consulting or Advisory Role - Deciphera
Research Funding - Merck (Inst)
 
Aisha Ghaus
No Relationships to Disclose
 
Mark Shackleton
Patents, Royalties, Other Intellectual Property - Royalty payments from discoveries that led to venetoclax (I)
Other Relationship - BMS; MSD
 
Yang Wang
No Relationships to Disclose
 
Shahneen Sandhu
Honoraria - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Skyline Diagnostics (Inst)
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Merck Sharp and Dohme (Inst); Novartis (Inst); Roche/Genentech (Inst); Skyline Diagnostics (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Senhwa Biosciences (Inst)
(OPTIONAL) Uncompensated Relationships - AAA/Endocyte/Novartis (Inst)
 
Jurgen Becker
Consulting or Advisory Role - Almirall; Boehringer Ingelheim; Icon Cancer Care; Pfizer; Regeneron
Speakers' Bureau - Amgen; Incyte; Merck Serono; Pfizer; Sanofi; Sun Pharma
Research Funding - Alcedis; IQVIA; Merck Serono; Regeneron
Travel, Accommodations, Expenses - Merck Serono
 
Marcin Dzienis
Consulting or Advisory Role - BMS Brazil; MSD; Novartis
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis
Travel, Accommodations, Expenses - MSD; Pierre Fabre
 
Liam Dwyer
No Relationships to Disclose
 
Jenny Lee
No Relationships to Disclose
 
Adnan Khattak
No Relationships to Disclose
 
Lydia Warburton
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis (I); Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme
 
Christopher Steer
Honoraria - AstraZeneca; Eisai; Novartis
Consulting or Advisory Role - Ipsen; Janssen; MSD; Sanofi
 
Wen Xu
Consulting or Advisory Role - BMS Brazil; Merck; MSD; Novartis
Speakers' Bureau - AZD; Bristol-Myers Squibb; Limbic Oncology; Merck; MSD
Research Funding - Merck
Travel, Accommodations, Expenses - AZD; Daiichi Sankyo; Merck; MSD